Correvio Pharma Corp. Finite-Lived Trade Names, Gross
Correvio Pharma Corp. had Finite-Lived Trade Names, Gross of $41.99 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedTradeNamesGross · last filed 2020-04-30
- 2019-12-31: Finite-Lived Trade Names, Gross $41.99M.
- 2018-12-31: Finite-Lived Trade Names, Gross $42.77M.
- 2017-12-31: Finite-Lived Trade Names, Gross $41.17M.
- 2016-12-31: Finite-Lived Trade Names, Gross $34.15M.
| Period end | Finite-Lived Trade Names, Gross |
|---|---|
| 2019-12-31 | $41.99M 20-F · filed 2020-04-30 |
| 2018-12-31 | $42.77M 20-F · filed 2020-04-30 |
| 2017-12-31 | $41.17M 40-F · filed 2019-03-13 |
| 2016-12-31 | $34.15M 20-F · filed 2018-04-30 |